166 related articles for article (PubMed ID: 8666689)
1. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease.
Halme L; Rautelin H; Leidenius M; Kosunen TU
J Clin Pathol; 1996 Jan; 49(1):65-7. PubMed ID: 8666689
[TBL] [Abstract][Full Text] [Related]
2. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease.
Wagtmans MJ; Witte AM; Taylor DR; Biemond I; Veenendaal RA; Verspaget HW; Lamers CB; van Hogezand RA
Scand J Gastroenterol; 1997 Jul; 32(7):712-8. PubMed ID: 9246713
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Pearce CB; Duncan HD; Timmis L; Green JR
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
[TBL] [Abstract][Full Text] [Related]
4. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine.
el-Omar E; Penman I; Cruikshank G; Dover S; Banerjee S; Williams C; McColl KE
Gut; 1994 Oct; 35(10):1385-8. PubMed ID: 7959192
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching.
Parente F; Molteni P; Bollani S; Maconi G; Vago L; Duca PG; Rembacken B; Axon AT; Bianchi Porro G
Scand J Gastroenterol; 1997 Nov; 32(11):1140-6. PubMed ID: 9399396
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor?
Väre PO; Heikius B; Silvennoinen JA; Karttunen R; Niemelä SE; Lehtola JK; Karttunen TJ
Scand J Gastroenterol; 2001 Dec; 36(12):1295-300. PubMed ID: 11761020
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication therapy is not associated with the onset of inflammatory bowel diseases. A case-control study.
Rosania R; Von Arnim U; Link A; Rajilic-Stojanovic M; Franck C; Canbay A; Malfertheiner P; Venerito M
J Gastrointestin Liver Dis; 2018 Jun; 27(2):119-125. PubMed ID: 29922755
[TBL] [Abstract][Full Text] [Related]
8. [Helicobacter pylori and nonspecific intestinal inflammation].
Münzová H; Dítĕ P; Sevcíková I; Dolina J; Novotný I; Kunovská M
Vnitr Lek; 2000 Dec; 46(12):839-42. PubMed ID: 11214362
[TBL] [Abstract][Full Text] [Related]
9. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study.
Duggan AE; Usmani I; Neal KR; Logan RF
Gut; 1998 Oct; 43(4):494-8. PubMed ID: 9824576
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study.
Ding ZH; Xu XP; Wang TR; Liang X; Ran ZH; Lu H
PLoS One; 2021; 16(3):e0248427. PubMed ID: 33711050
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of Helicobacter pylori gastritis in newly diagnosed children with inflammatory bowel disease.
Roka K; Roubani A; Stefanaki K; Panayotou I; Roma E; Chouliaras G
Helicobacter; 2014 Oct; 19(5):400-5. PubMed ID: 24827117
[TBL] [Abstract][Full Text] [Related]
12. [The prevalence of Helicobacter pylori infection in Korean patients with inflammatory bowel disease, a multicenter study].
Song MJ; Park DI; Hwang SJ; Kim ER; Kim YH; Jang BI; Lee SH; Ji JS; Shin SJ
Korean J Gastroenterol; 2009 Jun; 53(6):341-7. PubMed ID: 19556840
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment.
Guslandi M; Fanti L; Testoni PA
Hepatogastroenterology; 2002; 49(47):1296-7. PubMed ID: 12239929
[TBL] [Abstract][Full Text] [Related]
14. Serum anti-Helicobacter pylori IgA and IgG antibodies in asymptomatic children in Serbia.
Dinić M; Tasić G; Stanković-Dordević D; Otasević L; Tasić M; Karanikolic A
Scand J Infect Dis; 2007; 39(4):303-7. PubMed ID: 17454893
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and inflammatory bowel disease: is there a link?
Papamichael K; Konstantopoulos P; Mantzaris GJ
World J Gastroenterol; 2014 Jun; 20(21):6374-85. PubMed ID: 24914359
[TBL] [Abstract][Full Text] [Related]
16. High frequency of helicobacter negative gastritis in patients with Crohn's disease.
Halme L; Kärkkäinen P; Rautelin H; Kosunen TU; Sipponen P
Gut; 1996 Mar; 38(3):379-83. PubMed ID: 8675090
[TBL] [Abstract][Full Text] [Related]
17. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease.
Oliveira AG; Rocha GA; Rocha AM; Sanna Md; Moura SB; Dani R; Marinho FP; Moreira LS; Ferrari Mde L; Castro LP; Queiroz DM
Helicobacter; 2006 Feb; 11(1):2-9. PubMed ID: 16423084
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of upper gastrointestinal lesions and Helicobacter pylori infection in Crohn's disease.
D'Incà R; Sturniolo G; Cassaro M; di Pace C; Longo G; Callegari I; Rugge M
Dig Dis Sci; 1998 May; 43(5):988-92. PubMed ID: 9590412
[TBL] [Abstract][Full Text] [Related]
19. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of mast cells and macrophages in focal active gastritis of patients with Crohn's disease.
Furusu H; Murase K; Nishida Y; Isomoto H; Takeshima F; Mizuta Y; Hewlett BR; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):639-43. PubMed ID: 12063959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
